MedPath
FDA Approval

Metaxalone

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
January 11, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Metaxalone(800 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Amneal Pharmaceuticals of New York, LLC

Amneal Pharmaceuticals of New York LLC

123797875

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Metaxalone

Product Details

NDC Product Code
53746-553
Application Number
ANDA203399
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 11, 2023
FD&C RED NO. 40Inactive
Code: WZB9127XOAClass: IACT
CALCIUM CARBONATEInactive
Code: H0G9379FGKClass: IACT
Code: 1NMA9J598YClass: ACTIBQuantity: 800 mg in 1 1
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WOClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
SODIUM STEARYL FUMARATEInactive
Code: 7CV7WJK4UIClass: IACT
© Copyright 2025. All Rights Reserved by MedPath